Shares of PetMed Express Inc. (NASDAQ:PETS) saw strong trading volume on Thursday . 267,907 shares were traded during mid-day trading, an increase of 47% from the previous session’s volume of 182,398 shares.The stock last traded at $19.52 and had previously closed at $19.38.

A number of equities analysts recently issued reports on the company. Zacks Investment Research lowered PetMed Express from a “strong-buy” rating to a “hold” rating in a report on Monday. Craig Hallum raised PetMed Express from a “sell” rating to a “hold” rating in a report on Monday, May 9th.

The stock’s 50-day moving average price is $18.74 and its 200 day moving average price is $17.85. The stock has a market capitalization of $393.93 million and a PE ratio of 19.14.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings results on Monday, May 9th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.02. During the same period last year, the firm earned $0.25 EPS. The firm earned $55.40 million during the quarter, compared to analyst estimates of $50.20 million. PetMed Express’s quarterly revenue was up 10.8% on a year-over-year basis. On average, equities research analysts predict that PetMed Express Inc. will post $1.06 earnings per share for the current year.

In other news, CFO Bruce S. Rosenbloom sold 5,500 shares of the business’s stock in a transaction on Monday, May 9th. The shares were sold at an average price of $19.54, for a total value of $107,470.00. Following the completion of the transaction, the chief financial officer now owns 44,767 shares of the company’s stock, valued at approximately $874,747.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Several institutional investors have recently made changes to their positions in the stock. Rhumbline Advisers raised its position in shares of PetMed Express by 3.0% in the fourth quarter. Rhumbline Advisers now owns 67,377 shares of the company’s stock valued at $1,155,000 after buying an additional 1,940 shares during the period. WBI Investments Inc. boosted its stake in PetMed Express by 6.8% in the fourth quarter. WBI Investments Inc. now owns 100,469 shares of the company’s stock valued at $1,722,000 after buying an additional 6,425 shares in the last quarter. GSA Capital Partners LLP boosted its stake in PetMed Express by 38.0% in the fourth quarter. GSA Capital Partners LLP now owns 113,673 shares of the company’s stock valued at $1,948,000 after buying an additional 31,274 shares in the last quarter. Finally, Afam Capital Inc. boosted its stake in PetMed Express by 1.6% in the fourth quarter. Afam Capital Inc. now owns 145,512 shares of the company’s stock valued at $2,494,000 after buying an additional 2,224 shares in the last quarter.

PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds is a pet pharmacy. The Company markets prescription and non-prescription pet medications and other health products for dogs and cats, direct to the consumer. The Company offers a selection of products for dogs and cats. The Company’s product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.